Literature DB >> 17702659

Risk of pancreatitis in 14,000 individuals with celiac disease.

Jonas F Ludvigsson1, Scott M Montgomery, Anders Ekbom.   

Abstract

BACKGROUND & AIMS: The aim of this study was to examine the risk of pancreatitis in patients with celiac disease (CD) from a general population cohort.
METHODS: By using Swedish national registers, we identified 14,239 individuals with a diagnosis of CD (1964-2003) and 69,381 reference individuals matched for age, sex, calendar year, and county of residence at the time of diagnosis. Cox regression estimated the hazard ratios (HRs) for a subsequent diagnosis of pancreatitis. We restricted analyses to individuals with more than 1 year of follow-up and no diagnosis of pancreatitis before or within 1 year after study entry. Conditional logistic regression estimated the association of pancreatitis with subsequent CD.
RESULTS: CD was associated with an increased risk of subsequent pancreatitis of any type (HR, 3.3; 95% confidence interval [CI], 2.6-4.4; P < .001; on the basis of 95 positive events in individuals with CD vs 163 positive events in reference individuals) and chronic pancreatitis (HR, 19.8; 95% CI, 9.2-42.8; P < .001; on the basis of 37 and 13 positive events, respectively). Adjustment for socioeconomic index, diabetes mellitus, alcohol-related disorders, or gallstone disease had no notable effect on the risk estimates. The risk increase for pancreatitis was only found among individuals with CD diagnosed in adulthood. Pancreatitis of any type (odds ratio, 3.2; 95% CI, 2.5-4.3; P < .001) and chronic pancreatitis (odds ratio, 7.3; 95% CI, 4.0-13.5; P < .001) were associated with subsequent CD.
CONCLUSIONS: This study suggests that individuals with CD are at increased risk of pancreatitis.

Entities:  

Mesh:

Year:  2007        PMID: 17702659     DOI: 10.1016/j.cgh.2007.06.002

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  17 in total

1.  Fecal elastase: a useful test for pancreatic insufficiency?

Authors:  Jo Tod; David Fine
Journal:  Dig Dis Sci       Date:  2010-10       Impact factor: 3.199

2.  Isotretinoin use and celiac disease: a population-based cross-sectional study.

Authors:  Benjamin Lebwohl; Anders Sundström; Bana Jabri; Sonia S Kupfer; Peter H R Green; Jonas F Ludvigsson
Journal:  Am J Clin Dermatol       Date:  2014-12       Impact factor: 7.403

3.  Recurrent abdominal pain in a patient with Down syndrome.

Authors:  Allison Venner; Archana Kaza; Von G Samedi
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

4.  Patients with celiac disease have an increased risk for pancreatitis.

Authors:  Omid Sadr-Azodi; David S Sanders; Joseph A Murray; Jonas F Ludvigsson
Journal:  Clin Gastroenterol Hepatol       Date:  2012-07-16       Impact factor: 11.382

Review 5.  Chronic pancreatitis.

Authors:  Matthew J DiMagno; Eugene P DiMagno
Journal:  Curr Opin Gastroenterol       Date:  2013-09       Impact factor: 3.287

6.  Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans.

Authors:  Annelie M Landgren; Ola Landgren; Gloria Gridley; Graça M Dores; Martha S Linet; Lindsay M Morton
Journal:  Cancer       Date:  2010-11-02       Impact factor: 6.860

7.  Celiac disease diagnosis and management: a 46-year-old woman with anemia.

Authors:  Daniel Leffler
Journal:  JAMA       Date:  2011-10-12       Impact factor: 56.272

Review 8.  [Autoimmune pancreatitis].

Authors:  A Schneider; J M Löhr
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

9.  The Risk of Acute and Chronic Pancreatitis in Celiac Disease.

Authors:  Motasem Alkhayyat; Mohannad Abou Saleh; Mohammad Abureesh; George Khoudari; Thabet Qapaja; Emad Mansoor; C Roberto Simons-Linares; John Vargo; Tyler Stevens; Alberto Rubio-Tapia; Prabhleen Chahal
Journal:  Dig Dis Sci       Date:  2020-08-18       Impact factor: 3.199

10.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research.

Authors:  Jonas F Ludvigsson; Petra Otterblad-Olausson; Birgitta U Pettersson; Anders Ekbom
Journal:  Eur J Epidemiol       Date:  2009-06-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.